Frank McAllister, DO
Allergy & Immunology · Las Vegas, NVNPI 1114955762
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $761 of the $905 with a category attached, or 84.1%. CSL Behring accounts for 62.1% of it on its own, with 11 other manufacturers making up the rest.
Across 58 payments — averaging $15.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$562
- GSK$67
- Optinose US, Inc.$53
- AstraZeneca$51
- Genentech USA, Inc.$34
- Lilly USA, LLC$30
- plus $107 from 6 others
What the payments were for
- Food & beverage$76184%
- Education$14416%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 39 | $562 |
| GSK | 3 | $67 |
| Optinose US, Inc. | 3 | $53 |
| AstraZeneca | 3 | $51 |
| Genentech USA, Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $30 |
| Pfizer | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Biocryst US Sales Co., LLC | 1 | $16 |
| Sanofi | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
How this compares
Too few allergy & immunology providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 58 | $437 |
| Fluticasone Propionate | 44 | $363 |
| Methylprednisolone | 23 | $183 |
| Ciprofloxacin Hcl | 24 | $132 |
| Mupirocin | 15 | $119 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $62 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Las Vegas
- Jason BellakLas Vegas$41K
- Ricardo VinuyaLas Vegas$36K
- Matt MorganLas Vegas$12K
- Anthony NguyenLas Vegas$9K
- Joram SeggevLas Vegas$423
- Victor CohenLas Vegas$309
- Frederick HermanHenderson$35K
- Jeffrey NugentReno$12K
- Reece JonesReno$9K
- Andrew McKnightHenderson$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.